Oded Icht
YOU?
Author Swipe
View article: Assessment of the Effective Dose to Immune Cells as an Independent predictor of Durvalumab response in Non-Small Cell Lung Cancer patients after Chemoradiotherapy: A Multi-Center Study
Assessment of the Effective Dose to Immune Cells as an Independent predictor of Durvalumab response in Non-Small Cell Lung Cancer patients after Chemoradiotherapy: A Multi-Center Study Open
View article: Patterns of Failure for Patients with Thymoma Treated with Post Operative Radiation Therapy
Patterns of Failure for Patients with Thymoma Treated with Post Operative Radiation Therapy Open
View article: The role of a radiopaque peri-rectal hydrogel spacer in aiding accurate daily image-guidance for prostate stereotactic radiotherapy
The role of a radiopaque peri-rectal hydrogel spacer in aiding accurate daily image-guidance for prostate stereotactic radiotherapy Open
Introduction Precise patient positioning with image guidance (IGRT) is essential for safe prostate radiotherapy. We present the first report of utilizing a CT-visible hydrogel spacer, used to decrease rectal radiation dose, as a surrogate …
View article: SABR-Dual: a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer
SABR-Dual: a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer Open
Background Dose-escalated radiotherapy is known to improve progression free survival in patients with localized prostate cancer, and recent advances have led to the standardization of ultrahypofractionated stereotactic ablative radiotherap…
View article: Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment
Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment Open
Introduction Historically, patients with brain metastasis (BM) have been excluded from clinical trials investigating treatments for non-small cell lung cancer (NSCLC) due to their unfavorable prognosis. Advanced treatments have increased s…
View article: Converging Survival Trends in Non-Small Cell Lung Cancer Patients With and Without Brain Metastasis Receiving State-of-the-Art Treatment
Converging Survival Trends in Non-Small Cell Lung Cancer Patients With and Without Brain Metastasis Receiving State-of-the-Art Treatment Open
Introduction: Historically, patients with brain metastasis (BM) have been excluded from clinical trials investigating treatments for non-small cell lung cancer (NSCLC) due to their unfavorable prognosis. Advanced treatments have increased …
View article: SABR-Dual: A phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer
SABR-Dual: A phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer Open
Background: Dose-escalated radiotherapy is known to improve progression free survival in patients with localized prostate cancer, and recent advances have led to the standardization of ultrahypofractionated stereotactic ablative radiothera…
View article: Same-day versus delayed simulation imaging after placement of a perirectal hydrogel spacer for prostate radiotherapy
Same-day versus delayed simulation imaging after placement of a perirectal hydrogel spacer for prostate radiotherapy Open
Introduction Placement of a perirectal hydrogel spacer has been demonstrated to reduce the risk of rectal toxicity from prostate radiation. Practices vary regarding the timing of CT simulation after hydrogel placement, and the ideal schedu…
View article: Correlations between pathogenic variants in <scp>DNA</scp> repair genes and anticancer treatment efficacy in stage <scp>IV</scp> non‐small cell lung cancer: A large real‐world cohort and review of the literature
Correlations between pathogenic variants in <span>DNA</span> repair genes and anticancer treatment efficacy in stage <span>IV</span> non‐small cell lung cancer: A large real‐world cohort and review of the literature Open
Background Mutations in genes involved in DNA damage repair (DDR), a hallmark of cancer, are associated with increased cancer cell sensitivity to certain therapies. This study sought to evaluate the association of DDR pathogenic variants w…
View article: Arterial and Venous Thromboembolism in <i>ALK</i>-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study
Arterial and Venous Thromboembolism in <i>ALK</i>-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study Open
Introduction There is scarce data regarding the incidence of venous thromboembolism (VTE) and arterial thromboembolism (ATE) in the molecular subtypes of non-small cell lung cancer (NSCLC). We aimed to investigate the association between A…
View article: Higher Toxicity Rates Following Hypofractionated Radiotherapy in Early Glottic Cancer Patients
Higher Toxicity Rates Following Hypofractionated Radiotherapy in Early Glottic Cancer Patients Open
Context: Toxicity from radiation therapy for laryngeal squamous cell carcinoma includes dysphagia, mucositis, laryngeal edema, weight loss and pain. Hypofractionation (HF) regimens shorten the overall treatment time to lower the risk for a…
View article: Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy (IMRT) Compared With 3D Conformal Radiotherapy (3DCRT) for Patients With Locally Advanced Rectal Cancer: Prospective Phase II Study
Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy (IMRT) Compared With 3D Conformal Radiotherapy (3DCRT) for Patients With Locally Advanced Rectal Cancer: Prospective Phase II Study Open
View article: Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors
Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors Open
View article: Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases
Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases Open
Direct oral anticoagulants (DOACs) are increasingly prescribed in treatment of cancer-associated thrombosis, but limited data exist regarding safety of DOACs in patients with brain metastases. We aimed to determine the incidence of intracr…
View article: A phase II single arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated Classical Kaposi Sarcoma (CKS)
A phase II single arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated Classical Kaposi Sarcoma (CKS) Open
View article: P1.04-17 Tumour Burden as a Predictive Tool of Response to Immune Checkpoint Inhibitors (ICI) in Patients with Metastatic Non-Small-Cell Lung Cancer
P1.04-17 Tumour Burden as a Predictive Tool of Response to Immune Checkpoint Inhibitors (ICI) in Patients with Metastatic Non-Small-Cell Lung Cancer Open